￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Adverse reaction treatment methods and safe medication guide for DaliRasheng (Keweike)

2026-02-01 22:25:32

Check Details
Analysis of the dosage cycle and dosage standard of a box of Lynparza

2026-02-01 22:25:32

Check Details
Actual evaluation and data analysis of the therapeutic effect of venetoclax/venetoclax (venetoclax)

2026-02-01 22:25:32

Check Details
Analysis of the indications and clinical application of Asnib/Asiminib

2026-02-01 22:25:32

Check Details
Comprehensive interpretation of the indications and applicable groups of ritexitinib (Lefenox)

2026-02-01 22:25:32

Check Details
Standard dosage and individualized adjustment plan of sparsentan

2026-02-01 22:25:32

Check Details
Real evaluation and clinical data analysis of the therapeutic effect of Ixazomib (Enleri)

2026-02-01 22:25:32

Check Details
Analysis of clinical trial data and efficacy evaluation of rubitin/rubicatin (Zanbiga)

2026-02-01 22:25:32

Check Details
Introduction to dosage forms and specifications of Pimitespib and analysis of convenience of use

2026-02-01 22:25:32

Check Details
Analysis of the differences in efficacy and indications between afatinib (Gitarel) and osimertinib

2026-02-01 22:25:32

Check Details
Clinical efficacy and effectiveness evaluation of DaliRasheng (Keweike) in the treatment of insomnia disorder

2026-02-01 22:25:32

Check Details
Comparative efficacy and safety analysis of Lynparza and Fluzoparib

2026-02-01 22:25:32

Check Details
Category
相关知识